DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 203135
The generic ingredient in CALCIUM ACETATE is calcium acetate. There are two hundred and seventy-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
Summary for 203135
Tradename: | CALCIUM ACETATE |
Applicant: | Invagen Pharms |
Ingredient: | calcium acetate |
Patents: | 0 |
Therapeutic Class: | Genitourinary Agents Therapeutic Nutrients/Minerals/Electrolytes |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203135
Ingredient-type | Calcium Cations, Divalent |
Physiological Effect | Increased Coagulation Factor Activity |
Suppliers and Packaging for NDA: 203135
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 203135 | ANDA | Atlantic Biologicals Corps | 17856-0377 | N | 17856-0377-2 |
CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 203135 | ANDA | State of Florida DOH Central Pharmacy | 53808-1001 | N | 53808-1001-1 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 667MG | ||||
Approval Date: | Feb 7, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription